The writer Ta-Nehisi Coates joins Ezra Klein to discuss how the left should think about the work of politics and persuasion ...
First developed in the mid-20th century, the field of orientation and mobility teaches people with visual impairments ...
Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results